| |||||||
|
Assessing eHealth Markets Opportunities for Pharmaceutical Companies in Europe and the US Introduction: Presents Datamonitor’s recommendations for driving greater uptake of pharmaceutical company branded services and maximizing online exposure to physicians – specialists and primary care physicians – and consumers in six major markets: France, Germany, Italy, Spain, the UK and the US. Scope: * Evaluates the eHealth market in six major countries: France, Germany, Italy, Spain, the UK and the US * Assesses how physicians and patients want to use the Internet * Evaluates the growth of the ePrescribing market in the UK * Presents strategies to support the management of the patient-physician relationship in the US Report Highlights: Pharmaceutical companies should provide physicians in each of the six markets with convenient online access to disease and drug information. Online continuing medical education (eCME) programs serve as ideal tools for this purpose, and help to establish valued relationships with physicians. In the UK, the National Health Service’s Pharmacy in the Future scheme will result in growth in the ePrescribing market, which Datamonitor projects will drive greater use of handheld devices among physicians. The UK will act as a pioneer for Europe in the adoption of ePrescribing technologies.
In the US, companies must focus on supporting the management of the patient-physician relationship, by meeting demands for online disease management tools. Reasons to Purchase: * Plan market-specific strategies by understanding physician attitudes towards the use of emerging technologies for work-related purposes * Improve your online consumer marketing in each country by analyzing the current and potential consumer use of the Internet for health purposes * Capitalize on the unmet needs of under-developed eHealth markets such as Germany Publisher: Datamonitor eHealthcare Pharma Reports To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_eHealthcare_Pharma.html#a49
|
|